DrugDashboards

Furosemide

Furosemide · FUROSEMIDE 20 mg/2mL · Injection, Solution · Intramuscular; Intravenous · Medical Purchasing Solutions, LLC

NDC 71872-7236-01 · 1 VIAL in 1 BAG / 2 mL in 1 VIAL · ANDA · View full market →

The short version

21 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for furosemide (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · price up 19% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $6.22 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA212174
TE code
AP
Approval date
May 3, 2019
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)Apr 7, 2020
    Other
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)Apr 7, 2020
    Other
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • Planned discontinuation — Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)Apr 7, 2020
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)Apr 7, 2020
    Discontinuation of the manufacture of the drug
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • Planned discontinuation — Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)Apr 7, 2020
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)Apr 7, 2020
    Other
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)Apr 7, 2020
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)Apr 7, 2020
    Other
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25)Apr 7, 2020
    Demand increase for the drug
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Furosemide (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Camber Pharmaceuticals, Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Devatis Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
NorthStar Rx LLCFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Sagent PharmaceuticalsFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Avenacy Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCFUROSEMIDE 40 mg/4mLJul 15, 2026Sep 2, 2026
Eugia US LLCFUROSEMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCFUROSEMIDE 20 mg/2mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.FUROSEMIDE 20 mg/2mLJul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCFUROSEMIDE 20 mg/2mLJul 15, 2026Sep 2, 2026
Phlow CorporationFUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstFUROSEMIDE 10 mg/mLJul 15, 2026Aug 31, 2026
ProPharma DistributionFUROSEMIDE 10 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Furosemide — NDC 71872-7236-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71872723601.

Free to cite with attribution — see how the data is put together.